Please visit the following websites for more information on opportunities for industry to participate in research supported by the Special Diabetes Program:
: a network of clinical centers, investigators,
and core support facilities in the U.S. and Canada that supports the development
and implementation of clinical trials of agents to slow the progression of type
1 diabetes in new-onset patients and to prevent type 1 diabetes in those at-risk
of developing the disease.
: an international consortium that evaluates
promising tolerogenic treatment regimens in four clinical areas: islet transplantation,
kidney transplantation, autoimmune diseases, and asthma and allergy diseases.
The mission of DRCR.net is to facilitate
the conduct of multi-center clinical research of diabetic retinopathy, diabetic
macular edema, and associated conditions.
also has opportunities for industry partnerships.